go back

Utah rates for HCPCS Q2055

Idecabtagene vicleucel, up to 510 million autologous B-cell maturation antigen (BCMA) directed CAR-positive T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $645,654 · 10th–90th $645,654–$645,6540%50%100%$645,654Professionalmedian $562,341 · 10th–90th $562,341–$645,6540%50%90th$562,341

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$645,654.23 / $645,654.23 / $645,654.23
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $645,654.23
Select Health
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$575,439.94 / $575,439.94 / $575,439.94
U of Utah Health Plan
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$501,187.23 / $562,341.33 / $676,082.98
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $630,957.34